We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
+$5.9M
2
SPLK
Splunk Inc
SPLK
+$2.26M
3
COUP
Coupa Software Incorporated
COUP
+$2.15M
4
BKNG icon
Booking.com
BKNG
+$1.8M
5
PPLI
People Inc
PPLI
+$1.64M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
2
Z icon
Zillow
Z
+$3.18M
3
AGN
Allergan plc
AGN
+$2.69M
4
RNG icon
RingCentral
RNG
+$2.07M
5
REXR icon
Rexford Industrial Realty
REXR
+$2.04M

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KB icon
1051
KB Financial Group
KB
$41.5B
$10K ﹤0.01%
350
– –
XNCR icon
1052
Xencor
XNCR
$1.47B
$10K ﹤0.01%
320
– –
EIDX
1053
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10K ﹤0.01%
212
– –
WMGI
1054
PUT
DELISTED
Wright Medical Group Inc
WMGI
$10K ﹤0.01%
+300
New +$8.77K
ARVN icon
1055
Arvinas
ARVN
$530M
$9K ﹤0.01%
220
– –
AUPH icon
1056
Aurinia Pharmaceuticals
AUPH
$1.96B
$9K ﹤0.01%
596
– –
FATE icon
1057
Fate Therapeutics
FATE
$283M
$9K ﹤0.01%
410
– –
IRWD icon
1058
Ironwood Pharmaceuticals
IRWD
$644M
$9K ﹤0.01%
885
– –
TPTX
1059
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9K ﹤0.01%
202
– –
EPZM
1060
DELISTED
Epizyme, Inc
EPZM
$9K ﹤0.01%
571
– –
AMRN
1061
Amarin Corp
AMRN
$290M
$8K ﹤0.01%
100
– –
CLPR
1062
Clipper Realty
CLPR
$46.4M
$8K ﹤0.01%
1,500
– –
LKFT
1063
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$8K ﹤0.01%
40
– –
INSM icon
1064
Insmed
INSM
$22.7B
$8K ﹤0.01%
504
– –
PCRX icon
1065
Pacira BioSciences
PCRX
$1.04B
$8K ﹤0.01%
236
– –
SAGE
1066
DELISTED
Sage Therapeutics
SAGE
$8K ﹤0.01%
292
– –
AKCA
1067
DELISTED
Akcea Therapeutics Inc
AKCA
$8K ﹤0.01%
530
– –
ALK icon
1068
Alaska Air
ALK
$5.3B
$7K ﹤0.01%
248
– –
BHR
1069
Braemar Hotels & Resorts
BHR
$157M
$7K ﹤0.01%
4,273
– –
INVA icon
1070
Innoviva
INVA
$1.57B
$7K ﹤0.01%
572
– –
KPTI icon
1071
Karyopharm Therapeutics
KPTI
$161M
$7K ﹤0.01%
24
– –
LGND icon
1072
Ligand Pharmaceuticals
LGND
$5.96B
$7K ﹤0.01%
147
– –
RGNX icon
1073
Regenxbio
RGNX
$622M
$7K ﹤0.01%
208
– –
VCYT icon
1074
Veracyte
VCYT
$4.44B
$7K ﹤0.01%
276
– –
DRNA
1075
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7K ﹤0.01%
386
– –
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.